Monday, December 11, 2017

New Issue Published Current Cancer Drug Targets Vol 18 issue 1

8:54 PM    No comments
Read More

Monday, October 16, 2017

Most Citied Article : Role of Inflammation-Associated Microenvironment in Tumorigenesis and Metastasis

12:10 AM    1 comment
Read More

Thursday, October 12, 2017

New Issue Published Current Cancer Drug Targets Vol 17 issue 9

3:44 AM    1 comment
Read More

Monday, October 9, 2017

Free Trial Request

12:20 AM    No comments
Read More

Monday, October 2, 2017

Most Accessed Article : Influence of Aldo-keto Reductase 1C3 in Prostate Cancer - A Mini Review

12:45 AM    No comments
Read More

Monday, September 25, 2017

New Issue Published Current Cancer Drug Targets Vol 17 issue 8

3:22 AM    No comments
Read More

Tuesday, August 22, 2017

Free Trial Offer

12:03 AM    No comments
Read More

Tuesday, August 15, 2017

Most Accessed Article: CD20-based Immunotherapy of B-cell Derived Hematologic Malignancies

12:25 AM    No comments
Read More

Thursday, August 10, 2017

New Issue Published Current Cancer Drug Targets Vol 17 issue 7

4:35 AM    No comments
Read More

Sunday, August 6, 2017

Open Access Article:HR+, HER2– Advanced Breast Cancer and CDK4/6 Inhibitors: Mode of Action, Clinical Activity, and Safety Profiles

11:45 PM    No comments
Read More

Monday, July 31, 2017

Call For Paper

2:52 AM    No comments
Read More

Monday, July 17, 2017

Free Trial Request

2:31 AM    No comments
Read More

Monday, July 3, 2017

Most Accessed Article:Targeted Inhibition of Rictor/mTORC2 in Cancer Treatment: A New Era after Rapamycin

10:28 PM    No comments
Read More

New Issue Published Current Cancer Drug Targets Vol 17 issue 6

2:57 AM    No comments
Read More

Monday, June 12, 2017

Open Access Article : "HR+, HER2– Advanced Breast Cancer and CDK4/6 Inhibitors: Mode of action, Clinical Activity, and Safety Profiles"

8:38 PM    No comments
Read More

Sunday, June 4, 2017

Call For Paper

11:07 PM    No comments
Read More

Sunday, May 28, 2017

Free Trial Request

10:09 PM    No comments
Read More

Monday, May 22, 2017

Most Accessed Article Indoleamine 2,3-dioxygenase (IDO): Biology and Target in Cancer Immunotherapies

10:36 PM    No comments
Read More

Thursday, May 18, 2017

4:41 AM    No comments
Read More

Tuesday, May 9, 2017

Open Access Article: Advances in Synergistic Combinations of Chinese Herbal Medicine for the Treatment of Cancer

3:24 AM    No comments
Read More

Tuesday, April 18, 2017

Call For Paper

12:21 AM    No comments
Read More

Thursday, April 13, 2017

Free Trial Request

12:09 AM    No comments
Read More

Wednesday, April 5, 2017

Open Access Article: Unveiling the Role of Nuclear Transport in Epithelial-to-Mesenchymal Transition

2:11 AM    No comments
Read More

Wednesday, March 22, 2017

Most Accessed Article: Refractory Chronic Lymphocytic Leukemia: A Therapeutic Challenge

3:56 AM    No comments
Read More

Thursday, March 16, 2017

Call For Paper

11:26 PM    No comments
Read More

Wednesday, March 8, 2017

Free Trial Request

10:34 PM    No comments
Read More

Wednesday, March 1, 2017

Open Access Article: Pleiotropic Role of HSF1 in Neoplastic Transformation

10:29 PM    No comments
Read More

Tuesday, February 28, 2017

New Issue Published Current Cancer Drug Targets Vol. 17 Issue 3

11:49 PM    No comments
Read More

Monday, February 20, 2017

Most Accessed Article: Therapeutic Approach to Patients with Chronic Lymphocytic Leukemia and Significant Comorbid Conditions

9:48 PM    No comments
Read More

Wednesday, February 1, 2017

Free Online Issue Current Cancer Drug Targets Vol. 17 Issue 1

9:10 PM    No comments
Read More

Wednesday, January 25, 2017

Call For Paper

3:23 AM    No comments
Read More

Wednesday, January 18, 2017

Free Trial Request

9:17 PM    No comments
Read More

Wednesday, January 11, 2017

New Issue Published Current Cancer Drug Targets Vol. 17 Issue 2

3:19 AM    No comments
Read More

Tuesday, January 3, 2017

Most Accessed Article: Therapeutic Approach to Patients with Chronic Lymphocytic Leukemia and Significant Comorbid Conditions

3:34 AM    No comments
Read More

Highlighted Article: Pyrimethamine as a Potent and Selective Inhibitor of Acute Myeloid Leukemia Identified by High-throughput Drug Screening

3:30 AM    No comments
Read More

Open Access Article: A Comprehensive Outline of Trastuzumab Resistance Biomarkers in HER2 Overexpressing Breast Cancer

3:26 AM    No comments
Read More